EFFECT OF CEREBRAL INJURY ON CEREBROSPINAL FLUID CYCLIC AMP CONCENTRATION.MYLLYLA VV.1976; EUROP. NEUROL.; SWITZ.; DA. 1976; VOL. 14; NO 6; PP. 413-425; BIBL. 1 P. 1/2Article

EFFECT OF CONVULSIONS AND ANTICONVULSIVE DRUGS ON CEREBROSPINAL FLUID CYCLIC AMP IN RABBITS = EFFET DES CONVULSIONS ET DES DROGUES ANTICONVULSIVES SUR L'AMP CYCLIQUE DU LCR CHEZ LES LAPINSMYLLYLA VV.1976; EUROP. NEUROL.; SWITZ.; DA. 1976; VOL. 14; NO 2; PP. 97-107; BIBL. 2 P. 1/2Article

EVALUATION OF SUCCESSIVE COLLECTIONS OF CISTERNAL CEREBROSPINAL FLUID IN RATS, RABBITS, AND CATS = EVALUATION DES COLLECTES SUCCESSIVES DE LIQUIDE CEPHALORACHIDIEN CISTERNAL CHEZ DES RATS, DES LAPINS ET DES CHATSYLITALO P; HEIKKINEN ER; MYLLYLA VV et al.1976; EXPER. NEUROL.; U.S.A.; DA. 1976; VOL. 50; NO 2; PP. 330-336; BIBL. 1 P.Article

CEREBROSPINAL FLUID PROTEIN FINDINGS IN VARIOUS LOWER BACK PAIN SYNDROMESAHONEN A; MYLLYLA VV; HOKKANEN E et al.1979; ACTA NEUROL. SCAND.; DNK; DA. 1979; VOL. 60; NO 2; PP. 93-99; BIBL. 10 REF.Article

RECURRENT MULTIPLE CRANIAL NEUROPATHIES.HOKKANEN E; HALTIA T; MYLLYLA VV et al.1978; EUROP. NEUROL.; SWITZ.; DA. 1978; VOL. 17; NO 1; PP. 32-37; BIBL. 17 REF.Article

CEREBROSPINAL FLUID CONCENTRATION OF CYCLIC AMP IN CEREBROVASCULAR DISEASES = C DE L'AMP CYCLIQUE DU LCR DANS LES MALADIES CEREBRO-VASCULAIRESHEIKKINEN ER; MYLLYLA VV; HOKKANEN E et al.1976; EUROP. NEUROL.; SWITZ.; DA. 1976; VOL. 14; NO 2; PP. 129-137; BIBL. 2 P.Article

CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE CONCENTRATION AND ENZYME ACTIVITIES OF CEREBROSPINAL FLUID IN MENINGITIS OF CHILDREN = LES TAUX D'ADENOSINE-3',5'-MONOPHOSPHATE CYCLIQUE ET LES ACTIVITES ENZYMATIQUES DU LIQUIDE CEPHALO-RACHIDIEN DANS LA MENINGITE DE L'ENFANTHEIKKINEN ER; SIMILA S; MYLLYLA VV et al.1975; Z. KINDERHEILKDE; DTSCH.; DA. 1975; VOL. 120; NO 4; PP. 243-250; BIBL. 1 P. 1/2Article

EFFECT OF DIAZEPAM AND TOFIZOPAM ON SINGLE-FIBRE EMG FINDINGS IN MYASTHENIC PATIENTS AND HEALTHY SUBJECTSMYLLYLA VV; TOIVAKKA E; HOKKANEN E et al.1982; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1982; VOL. 31; NO 5; PP. 673-678; BIBL. 11 REF.Article

TOLFENAMIC ACID AND ERGOTAMINE ABUSEALA HURULA V; MYLLYLA VV; HOKKANEN E et al.1981; HEADACHE; ISSN 0017-8748; USA; DA. 1981; VOL. 21; NO 6; PP. 240-242; BIBL. 10 REF.Article

PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND HEPATIC CYTOCHROME P-450 CONCENTRATIONS IN EPILEPTICS UNDERGOING ANTICONVULSANT TREATMENTLUOMA PV; SOTANIEMI EA; PELKONEN RO et al.1980; SCAND. J. CLIN. LAB. INVEST.; NOR; DA. 1980; VOL. 40; NO 2; PP. 163-167; BIBL. 21 REF.Article

PLASMA-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN EPILEPTICS TREATED WITH VARIOUS ANTICONVULSANTSLUOMA PV; MYLLYLA VV; SOTANIEMI EA et al.1980; EUROP. NEUROL.; CHE; DA. 1980; VOL. 19; NO 1; PP. 67-72; BIBL. 20 REF.Article

BRACHIAL PLEXUS AND RADICULAR NEUROGRAPHY IN RELATION TO CORTICAL EVOKED RESPONSESSIIVOLA J; MYLLYLA VV; SULG I et al.1979; J. NEUROL. NEUROSURG. PSYCHIATRY; GBR; DA. 1979; VOL. 42; NO 12; PP. 1151-1158; BIBL. 14 REF.Article

CHANGES IN COLLAGEN METABOLISM IN DISEASED MUSCLE. I: BIOCHEMICAL STUDIESMYLLYLA R; MYLLYLA VV; TOLONEN U et al.1982; ARCH. NEUROL. (CHIC.); ISSN 0003-9942; USA; DA. 1982; VOL. 39; NO 12; PP. 752-759; BIBL. 40 REF.Article

EFFICACY OF SMALL DOSES OF BROMOCRIPTINE IN PARKINSON'S DISEASEMYLLYLA VV; SAARINEN A; YLOSTALO P et al.1983; CURRENT THERAPEUTIC RESEARCH; ISSN 0011-393X; USA; DA. 1983; VOL. 33; NO 1; PP. 144-149; BIBL. 19 REF.Article

CYCLIC AMP CONCENTRATION AND ENZYME ACTIVITIES OF CEREBROSPINAL FLUID IN PATIENTS WITH EPILEPSY OR CENTRAL NERVOUS SYSTEM DAMAGE = CONCENTRATION D'AMP CYCLIQUE ET ACTIVITES DES ENZYMES DU LCR CHEZ LES MALADES AVEC UNE EPILEPSIE OU UNE LESION DU SNCMYLLYLA VV; HEIKKINEN ER; VAPAATALO H et al.1975; EUROP. J. NEUROL.; SWITZ.; DA. 1975; VOL. 13; NO 2; PP. 123-130; BIBL. 1P.1/2Article

URINARY EXCRETION AND CEREBROSPINAL FLUID CONCENTRATION OF CYCLIC ADENOSINE-3PRIME ,5PRIME -MONOPHOSPHATE IN VARIOUS NEUROLOGICAL DISEASES = EXCRETION URINAIRE ET CONCENTRATION CEPHALORACHIDIENNE DE L'ADENOSINE CYCLIQUE-3PRIME ,5PRIME -MONOPHOSPHATE DANS DIVERSES MALADIES NEUROLOGIQUESHEIKKINEN ER; MYLLYLA VV; VAPAATALO H et al.1974; EUROP. NEUROL.; SWITZ.; DA. 1974; VOL. 11; NO 5; PP. 270-280; BIBL. 2P.Serial Issue

SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE AFTER ORAL, RECTAL AND INTRAMUSCULAR ADMINISTRATIONALA HURULA V; MYLLYLA VV; ARVELA P et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 15; NO 1; PP. 51-55; BIBL. 12 REF.Article

SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE IN CONTINUOUS MEDICATIONMYLLYLA VV; ALA HURULA V; ARVELA P et al.1980; UPS. J. MED. SCI., SUPPL.; ISSN 0300-9726; SWE; DA. 1980; NO 31; PP. 20-22; BIBL. 6 REF.Article

JUVENILE AMYTROPHIC LATERAL SCLEROSIS: A REPORT OF TWO CASES IN A SINGLE FAMILYMYLLYLA VV; TOIVAKKA E; ALA HURULA V et al.1979; ACTA NEUROL. SCAND.; DNK; DA. 1979; VOL. 60; NO 3; PP. 170-177; BIBL. 17 REF.Article

SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE AFTER THREE SUCCESSIVE DOSES AND DURING CONTINUOUS MEDICATIONALA HURULA V; MYLLYLA VV; ARVELA P et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 16; NO 5; PP. 355-360; BIBL. 12 REF.Article